Labetalol
Labetalol is a blood pressure-lowering medication used to treat high blood pressure (hypertension), including severe hypertension requiring urgent control.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 70 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Labetalol: Patient Information Guide
A plain-language walkthrough of Labetalol — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Labetalol is approved to lower blood pressure across several products and forms:
- Labetalol HCL and Labetalol Hydrochloride tablets (oral) are indicated for the management of hypertension (high blood pressure) — used alone or in combination with diuretics
- LABETALOL HCl, Labetalol HCl in Dextrose, Labetalol HCl in Sodium Chloride, and Labetalol Hydrochloride injections (intravenous) are indicated specifically for severe hypertension requiring rapid control in a hospital setting
- Lowering blood pressure with labetalol reduces the risk of serious cardiovascular events, primarily stroke and heart attack
⚙️How it works▾
Labetalol blocks two sets of receptors simultaneously: alpha-1 receptors and beta receptors. Blocking alpha-1 receptors causes blood vessels to relax and widen, reducing the resistance the heart pumps against. Blocking beta receptors slightly slows the heart rate and reduces how hard the heart pumps. Together, these effects lower blood pressure without causing the reflex speeding of the heart that can happen with some other blood pressure medicines.
Because it blocks alpha-1 receptors, labetalol lowers blood pressure more when you are standing than when lying down. This means lightheadedness on standing can occur, particularly shortly after a dose change. The balance of alpha to beta blockade differs between the oral and intravenous routes, so the two forms have somewhat different hemodynamic profiles.
💊How it's taken▾
Labetalol is available as an oral tablet and as an intravenous injection — these two forms are used in very different situations and are not interchangeable.
- Tablets (Labetalol HCL, Labetalol Hydrochloride): Taken by mouth, generally twice daily. Taking them with food increases absorption. Your doctor will start at a low dose and adjust gradually based on your blood pressure readings.
- Injection (LABETALOL HCl, Labetalol HCl in Dextrose, Labetalol HCl in Sodium Chloride, Labetalol Hydrochloride): Given only intravenously in a hospital by healthcare professionals, either as repeated injections or a slow continuous infusion, with blood pressure monitored throughout.
Always follow your prescriber's specific instructions. Never adjust your dose or stop taking labetalol on your own.
🤒Side effects — in detail▾
Most side effects of labetalol are mild and tend to appear early in treatment. Common ones include:
- Dizziness or lightheadedness, especially when standing up quickly
- Fatigue or general tiredness
- Nausea
- Headache
- Weakness
- Vomiting
- Tingling of the scalp or skin
Serious reactions — including liver injury (jaundice, dark urine, persistent appetite loss), signs of heart failure (worsening breathlessness), sudden severe low blood pressure, or severe low blood sugar — require prompt medical attention. Do not wait to contact your doctor if these occur.
⚠️Warnings & precautions▾
- Liver damage: Labetalol can rarely cause serious liver injury, including liver failure and death. Watch for yellowing skin or eyes, dark urine, loss of appetite, right-sided abdominal pain, or flu-like symptoms. If these appear, stop labetalol and seek medical care immediately.
- Do not stop suddenly: Abruptly stopping labetalol — especially with coronary artery disease — can trigger severe chest pain or heart attack. Always taper under medical supervision.
- Heart failure: Labetalol can worsen heart failure in some patients. Report any new or worsening shortness of breath or swelling to your doctor.
- Breathing problems: Labetalol should generally not be used in people with asthma or obstructive airway disease, as it can cause bronchospasm (airway tightening).
- Diabetes: Labetalol can mask a fast heartbeat — one of the early warning signs of low blood sugar (hypoglycemia). Monitor blood sugar carefully and seek emergency help for severe hypoglycemia.
- Postural hypotension: Blood pressure drops more when standing than lying down; lightheadedness or fainting can occur, especially 2–4 hours after a dose.
- Surgery: Inform your anesthesiologist that you take labetalol — a dangerous interaction with certain anesthetics (notably halothane) can cause excessive blood pressure drops.
🔀What it interacts with▾
Several medicines and substances can interact with labetalol in clinically important ways:
- Tricyclic antidepressants (e.g., amitriptyline) — may increase the risk of tremor when combined with labetalol
- Cimetidine (heartburn medicine) — raises labetalol blood levels; dose adjustments may be needed
- Halothane anesthesia — can cause an extreme drop in blood pressure when used with intravenous labetalol; your surgical team must be informed
- Nitroglycerin — labetalol can amplify the blood pressure-lowering effect; extra monitoring is needed in patients with angina
- Verapamil-type calcium channel blockers — additive effects on heart rate and blood pressure; use with caution
- Digitalis glycosides (e.g., digoxin) — both slow heart conduction; combining them raises the risk of bradycardia (dangerously slow heart rate)
- Beta-agonist bronchodilators (e.g., albuterol) — labetalol can reduce their effectiveness in people with breathing problems
- Epinephrine (used for severe allergic reactions) — may be less effective in people on labetalol who have a history of severe allergic reactions
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not take labetalol if you have bronchial asthma or a history of obstructive airway disease — this is a strict contraindication
- Do not take it if you have overt heart failure, cardiogenic shock, severe bradycardia, or greater-than-first-degree heart block
- Tell your doctor if you have liver disease — labetalol can cause liver injury, and liver problems increase drug exposure in your body
- Tell your doctor if you have diabetes — labetalol can hide early signs of low blood sugar
- Tell your doctor if you have coronary artery disease — stopping labetalol suddenly is dangerous
- Tell your doctor if you have a pheochromocytoma (a type of adrenal tumor) — labetalol can occasionally cause a paradoxical rise in blood pressure in these patients
- Pregnancy: Labetalol crosses the placenta and has been associated with low blood pressure, slow heart rate, and low blood sugar in newborns. Use only if your doctor determines the benefit outweighs the risk.
- Breastfeeding: Small amounts pass into breast milk; discuss the risk-benefit with your doctor
- Children: Safety and effectiveness have not been established in pediatric patients
- Older adults (60+): More likely to experience dizziness and lightheadedness when standing; take extra precautions to prevent falls
🚑If you take too much▾
Too much labetalol can cause a severe drop in blood pressure (especially when standing) and sometimes a dangerously slow heart rate. If an overdose is suspected, seek emergency medical care immediately — lie flat with legs elevated to help maintain blood flow to the brain. Dialysis does not effectively remove labetalol from the body, so hospital-based supportive treatment is essential.
📡Pharmacodynamics — effects in the body▾
Labetalol lowers blood pressure by simultaneously relaxing blood vessels (via alpha-1 blockade) and reducing the heart's workload (via beta blockade), producing a dose-related fall in blood pressure without a compensatory increase in heart rate. It also blunts the blood pressure and heart rate spikes caused by exercise. Blood pressure is lowered more when standing than when lying down because of the alpha-blocking effect, which can lead to lightheadedness on standing — most likely 2 to 4 hours after a dose.
🔬Pharmacokinetics — how your body processes it▾
After an oral dose, labetalol is fully absorbed from the gut, with peak blood levels reached within 1 to 2 hours. However, only about 25% of an oral dose reaches the bloodstream because of extensive first-pass metabolism in the liver — and taking it with food increases that amount. The drug has a half-life of about 6 to 8 hours after oral dosing, and steady blood levels are typically reached by the third day of regular dosing.
Labetalol is broken down mainly in the liver and excreted primarily through the urine. Liver impairment increases drug exposure. Neither hemodialysis nor peritoneal dialysis removes meaningful amounts of labetalol from the body. In older adults, elimination may be slower, generally meaning lower maintenance doses are needed.
📦How to store it▾
stored at 20° to 25°C (68° to 77°F) . Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).
📄 Written from Labetalol’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Labetalol
176 supplements and herbal products have documented interactions with Labetalol in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 8
- Moderate · 148
- Minor · 20
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Labetalol has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Labetalol — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is labetalol used for? ▾
Is it okay to stop taking labetalol if I feel fine? ▾
I feel dizzy when I stand up after taking labetalol — is that normal? ▾
What side effects should I actually watch out for? ▾
Can I take labetalol if I'm pregnant or breastfeeding? ▾
Are there medicines I should avoid while taking labetalol? ▾
Is Labetalol available over the counter? ▾
When was Labetalol first available? ▾
Who makes Labetalol? ▾
💬 Answers drafted from Labetalol’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Labetalol comes
Labetalol is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Labetalol HCL and Labetalol Hydrochloride tablets are used to treat high blood pressure (hypertension)
- Labetalol HCL and Labetalol Hydrochloride tablets may be used alone or combined with other blood pressure medicines, especially diuretics
- Labetalol HCL and Labetalol Hydrochloride tablets are taken by mouth, typically twice daily
- Taking labetalol tablets with food increases the amount the body absorbs
- Dosage is individualized — your doctor will adjust your dose gradually based on your blood pressure response
- Do not stop taking labetalol tablets suddenly without talking to your doctor first
Injection
How this form is used
- LABETALOL HCl, Labetalol HCl in Dextrose, Labetalol HCl in Sodium Chloride, and Labetalol Hydrochloride injections are used to lower blood pressure in severe hypertension in hospitalized patients
- LABETALOL HCl, Labetalol HCl in Dextrose, Labetalol HCl in Sodium Chloride, and Labetalol Hydrochloride injections are given only intravenously (into a vein) by healthcare professionals in a hospital
- Patients must remain lying flat (supine) during intravenous administration — standing up can cause a significant blood pressure drop
- Labetalol HCl in Dextrose and Labetalol HCl in Sodium Chloride are ready-to-use solutions and do not require further dilution; no other medications should be added to the bag
- The ability to stand safely must be confirmed by hospital staff before the patient is allowed to get up after receiving the injection
Inhaler
📊 Labetalol across the U.S. market
How Labetalol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (15) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Labetalol is used
A general measure of how commonly Labetalol is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Labetalol is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Labetalol prescribed? Of the 1,597 medications we measure, Labetalol ranks #257 by Medicaid prescriptions — more than 84% of them.
Utilization by Labetalol product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
labetalol hydrochloride 200 MG Oral Tablet Most dispensed
Summed across the 17 of 119 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896762
labetalol hydrochloride 100 MG Oral Tablet
Summed across the 18 of 129 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896758
labetalol hydrochloride 300 MG Oral Tablet
Summed across the 14 of 108 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896766
labetalol hydrochloride 5 MG/ML Injectable Solution
Summed across the 10 of 39 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896771
4 ML labetalol hydrochloride 5 MG/ML Cartridge
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1234256
labetalol hydrochloride 400 MG Oral Tablet
Summed across the 1 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896983
4 ML labetalol hydrochloride 5 MG/ML Injection
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2477889
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Labetalol, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 62 of 409 listed Labetalol NDCs with Medicaid activity.
🔍 Compare Labetalol products
A representative set of FDA-listed product records for Labetalol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhaler | ||||
| 200 mg | — | Piramal Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 300 mg | — | Piramal Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 400 mg | — | Piramal Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 💊Injection | ||||
| 5 mg/mL | Intravenous | Akorn | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Almaject, Inc. × 4 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Alvogen Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Baxter Healthcare Corporation × 9 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Caplin Steriles Limited × 4 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Cardinal Health | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Cardinal Health 107, LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Civica, Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Fosun Pharma USA Inc. × 6 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Gland Pharma Limited × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 1 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. × 8 listings | NDA | View NDC → |
| 5 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. × 3 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | NDA | View NDC → |
| 5 mg/mL | Intravenous | Hospira, Inc. × 8 listings | ANDA | View NDC → |
| 100 mg/20 mL | Intravenous | Mullan Pharmaceutical Inc. | ANDA | View NDC → |
| 200 mg/40 mL | Intravenous | Mullan Pharmaceutical Inc. | ANDA | View NDC → |
| 5 mg/mL | Intravenous | NorthStar Rx LLC | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Onesource Specialty Pharma Limited × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 5 mg/mL | Intravenous | West-Ward Pharmaceuticals Corp × 3 listings | ANDA | View NDC → |
| 💊Tablet | ||||
| 100 mg | Oral | A-S Medication Solutions × 2 listings | NDA | Find on DailyMed ↗ |
| 100 mg | Oral | A-S Medication Solutions × 6 listings | ANDA | View NDC → |
| 200 mg | Oral | A-S Medication Solutions × 11 listings | ANDA | View NDC → |
| 300 mg | Oral | A-S Medication Solutions × 8 listings | ANDA | View NDC → |
| 100 mg | — | Actavis Pharma, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 100 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 200 mg | — | Actavis Pharma, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 300 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Advagen Pharma Ltd × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | Advagen Pharma Ltd × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Advagen Pharma Ltd × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Alvogen Inc. | NDA | View NDC → |
| 200 mg | Oral | Alvogen Inc. | NDA | View NDC → |
| 300 mg | Oral | Alvogen Inc. | NDA | View NDC → |
| 100 mg | Oral | American Health Packaging × 3 listings | ANDA | View NDC → |
| 200 mg | Oral | American Health Packaging × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | American Health Packaging × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Biocon Pharma Inc. × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | Biocon Pharma Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Biocon Pharma Inc. × 2 listings | ANDA | View NDC → |
| 400 mg | Oral | Biocon Pharma Inc. | ANDA | View NDC → |
| 100 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 200 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 300 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 100 mg | Oral | BluePoint Laboratories Inc. × 3 listings | ANDA | View NDC → |
| 200 mg | Oral | BluePoint Laboratories Inc. × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | BluePoint Laboratories Inc. × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Bryant Ranch Prepack × 8 listings | ANDA | View NDC → |
| 200 mg | Oral | Bryant Ranch Prepack × 9 listings | ANDA | View NDC → |
| 300 mg | Oral | Bryant Ranch Prepack × 6 listings | ANDA | View NDC → |
| 100 mg | Oral | Chartwell RX, LLC × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | Chartwell RX, LLC × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Chartwell RX, LLC × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 100 mg | Oral | Epic Pharma, LLC | ANDA | View NDC → |
| 200 mg | Oral | Epic Pharma, LLC | ANDA | View NDC → |
| 300 mg | Oral | Epic Pharma, LLC | ANDA | View NDC → |
| 100 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 400 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 100 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 200 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 300 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 100 mg | Oral | St. Mary's Medical Park Pharmacy | NDA | Find on DailyMed ↗ |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Alivus Life Sciences Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | American Pacific Corporation | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | Cadila Pharmaceuticals Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Cambrex Profarmaco Milano Srl | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | COSMA Spa | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Derivados Quimicos SAU | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Neuland Laboratories Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Olon SpA | BULK INGREDIENT | View NDC → |
| 50 kg/50 kg | — | PROCOS S.p.A. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Spectrum Laboratory Products, Inc. × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Srini Pharmaceuticals Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Unichem Laboratories Limited, India | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Viyash Life Sciences Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Viyash Scientific Limited | BULK INGREDIENT | View NDC → |
Showing 200 of 384 products — FDA National Drug Code Directory. See every product, package size and price: browse all 384 Labetalol NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Labetalol — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Labetalol in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Labetalol went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 6185 5 dose forms · 13 strengths
-
Dose form (SCDF) Cartridge RxCUI 1666588No current FDA listingClinical drug / strength (SCD) 4 ML labetalol hydrochloride 5 MG/MLRxCUI 1234256 -
Dose form (SCDF) Injectable Solution RxCUI 377107In current FDA listingsClinical drug / strength (SCD) hydrochloride 5 MG/MLRxCUI 896771 -
Dose form (SCDF) Injection RxCUI 2477888In current FDA listingsClinical drug / strength (SCD) 4 ML labetalol hydrochloride 5 MG/MLRxCUI 2477889100 ML labetalol hydrochloride 1 MG/MLRxCUI 2479566200 ML labetalol hydrochloride 1 MG/MLRxCUI 2479564300 ML labetalol hydrochloride 1 MG/MLRxCUI 2479567 -
Dose form (SCDF) Oral Tablet RxCUI 372554In current FDA listingsClinical drug / strength (SCD) hydrochloride 100 MGRxCUI 896758hydrochloride 200 MGRxCUI 896762hydrochloride 300 MGRxCUI 896766hydrochloride 400 MGRxCUI 896983hydrochloride 50 MGRxCUI 896987 -
Dose form (SCDF) Prefilled Syringe RxCUI 2598342No current FDA listingClinical drug / strength (SCD) 2 ML labetalol hydrochloride 5 MG/MLRxCUI 25983434 ML labetalol hydrochloride 5 MG/MLRxCUI 2727439
Look up RxCUI 6185 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Labetalol is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Labetalol belongs to the beta-Adrenergic Blocker class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 70 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Marlex Pharmaceuticals Inc is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.